Skip to content

Clinical Efficacy Observation of Electroacupuncture in Treating Postherpetic Neuralgia and Heart Rate Variability Study

Clinical Efficacy Observation of Electroacupuncture in Treating Postherpetic Neuralgia and Heart Rate Variability Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002470
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia

Interventions

Electroacupuncture Group:Electroacupuncture
Sham electroacupuncture group:Dummy Electroacupuncture

Sponsors

Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for postherpetic neuralgia and have a VAS score =4 points. 2. Aged 18-75 years, regardless of gender. 3. Patients with herpes zoster lesions located in the chest/abdominal area. 4. PHN patients who agree to use acute pain relief medications. 5. Informed consent and voluntary participation. Informed consent process should comply with GCP regulations. Note: Only patients meeting all 5 criteria above can be included.

Exclusion criteria

Exclusion criteria: 1. Patients taking tricyclic antidepressants for emotional issues or unable to cooperate with questionnaire completion; 2. Patients with severe primary/organic diseases or immune disorders; 3. Pregnant or lactating women; 4. Participants in other clinical trials during treatment period; 5. Patients with intellectual/behavioral impairments preventing informed consent; 6. Suspected or confirmed history of alcohol/drug abuse; 7. Other conditions that may reduce enrollment likelihood or complicate participation per investigator's judgment (e.g., frequent job/environment changes leading to loss of follow-up); 8. Allergic constitution (history of allergy to =2 medications/foods) or known allergy to trial drug components. Note: Patients meeting any of the above criteria should be excluded.

Design outcomes

Primary

MeasureTime frame
McGill Pain Questionnaire Score;

Secondary

MeasureTime frame
Heart Rate Variability;Hamilton Anxiety Rating Scale;Hamilton Depression Rating Scale;Pittsburgh Sleep Quality Index;Pain Improvement Time;

Countries

China

Contacts

Public ContactZhu Juan

Jiangsu Provincial Hospital of Traditional Chinese Medicine

juan_zhu1982@163.com13814002186

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026